Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8658641
APP PUB NO 20110245224A1
SERIAL NO

13124889

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds of Formula (I); to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to methods for their preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ENTASIS THERAPEUTICS INCCORPORATION TRUST CENTER 1209 ORANGE STREET WILMINGTON DE 19801

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barvian, Kevin Waltham, US 3 133
Basarab, Gregory Steven Waltham, US 17 200
Gowravaram, Madhusudhan Reddy Waltham, US 7 148
Hauck, Sheila Irene Waltham, US 15 214
Zhou, Fei Waltham, US 344 2621

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 25, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00